What if say tens of thousands of patients are successfully treated in indonesia, without adverse reactions? You can be sure that western countries will watch keenly into that type of development.
The Indonesian path just makes it a faster and much much cheaper route to trial, and by placing patents in advance to RCE's designtated countries, it will prove to be a very wise and well guarded move. **if all goes well...whenever that is**
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-45
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 45.5¢ | $347.1K | 751.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 89162 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 19756 | 5 |
View Market Depth
| Last trade - 13.21pm 10/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |